Mona Ashiya

2.8k total citations · 2 hit papers
8 papers, 2.3k citations indexed

About

Mona Ashiya is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Mona Ashiya has authored 8 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Endocrinology, Diabetes and Metabolism and 1 paper in Pharmacology. Recurrent topics in Mona Ashiya's work include RNA Research and Splicing (3 papers), RNA and protein synthesis mechanisms (3 papers) and Cell death mechanisms and regulation (2 papers). Mona Ashiya is often cited by papers focused on RNA Research and Splicing (3 papers), RNA and protein synthesis mechanisms (3 papers) and Cell death mechanisms and regulation (2 papers). Mona Ashiya collaborates with scholars based in United States. Mona Ashiya's co-authors include Stanley J. Korsmeyer, Solly Weiler, Atan Gross, Michael C. Wei, Tullia Lindsten, Vamsi K. Mootha, Scott A. Oakes, Luca Scorrano, Karolyn Buttle and Carmen A. Mannella and has published in prestigious journals such as Genes & Development, Nature Biotechnology and Nature Reviews Drug Discovery.

In The Last Decade

Mona Ashiya

8 papers receiving 2.3k citations

Hit Papers

tBID, a membrane-targeted death ligand, oligomerizes BAK ... 2000 2026 2008 2017 2000 2002 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mona Ashiya United States 7 2.0k 288 217 206 175 8 2.3k
Atan Gross Israel 19 2.0k 1.0× 326 1.1× 302 1.4× 288 1.4× 324 1.9× 31 2.5k
François Gonzalvez France 14 1.4k 0.7× 196 0.7× 238 1.1× 137 0.7× 175 1.0× 15 1.6k
Jean‐Pierre Jaffrézou France 29 2.1k 1.1× 154 0.5× 312 1.4× 451 2.2× 157 0.9× 45 2.7k
Masashi Morita Japan 21 1.6k 0.8× 113 0.4× 334 1.5× 389 1.9× 214 1.2× 89 2.1k
Geeta Datta United States 29 1.0k 0.5× 362 1.3× 398 1.8× 128 0.6× 404 2.3× 63 2.6k
Lucia Cilenti United States 17 1.3k 0.6× 266 0.9× 264 1.2× 242 1.2× 160 0.9× 29 1.8k
Aisha Shamas‐Din Canada 13 1.5k 0.7× 229 0.8× 226 1.0× 220 1.1× 211 1.2× 17 1.9k
Katherine S. Koch United States 22 827 0.4× 221 0.8× 72 0.3× 229 1.1× 138 0.8× 44 1.7k
Stefani N. Thomas United States 24 1.4k 0.7× 127 0.4× 221 1.0× 192 0.9× 180 1.0× 61 2.1k
Walter J. Esselman United States 21 1.1k 0.5× 150 0.5× 511 2.4× 145 0.7× 112 0.6× 50 1.8k

Countries citing papers authored by Mona Ashiya

Since Specialization
Citations

This map shows the geographic impact of Mona Ashiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Ashiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Ashiya more than expected).

Fields of papers citing papers by Mona Ashiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona Ashiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Ashiya. The network helps show where Mona Ashiya may publish in the future.

Co-authorship network of co-authors of Mona Ashiya

This figure shows the co-authorship network connecting the top 25 collaborators of Mona Ashiya. A scholar is included among the top collaborators of Mona Ashiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona Ashiya. Mona Ashiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ashiya, Mona & Richard Smith. (2007). Non-insulin therapies for type 2 diabetes. Nature Reviews Drug Discovery. 6(10). 777–778. 43 indexed citations
2.
Smith, Richard & Mona Ashiya. (2007). Antihypertensive therapies. Nature Reviews Drug Discovery. 6(8). 597–598. 46 indexed citations
3.
Scorrano, Luca, Mona Ashiya, Karolyn Buttle, et al.. (2002). A Distinct Pathway Remodels Mitochondrial Cristae and Mobilizes Cytochrome c during Apoptosis. Developmental Cell. 2(1). 55–67. 890 indexed citations breakdown →
4.
Sagar, Ambuj, Arthur Daemmrich, & Mona Ashiya. (2000). The tragedy of the commoners: biotechnology and its publics. Nature Biotechnology. 18(1). 2–4. 47 indexed citations
5.
Wei, Michael C., Tullia Lindsten, Vamsi K. Mootha, et al.. (2000). tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes & Development. 14(16). 2060–2071. 1049 indexed citations breakdown →
6.
Ashiya, Mona & Paula J. Grabowski. (1997). A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.. PubMed. 3(9). 996–1015. 189 indexed citations
7.
Zhang, L, Mona Ashiya, Thomas G. Sherman, & Paula J. Grabowski. (1996). Essential nucleotides direct neuron-specific splicing of gamma 2 pre-mRNA.. PubMed. 2(7). 682–98. 47 indexed citations
8.
Ashiya, Mona, et al.. (1995). Regulated splicing of gamma2 pre-messenger RNA in neuronal cells.. PubMed. 215–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026